CE: DETAIL

Golimumab: A Tumor Necrosis Factor Alpha Inhibitor for the Treatment of Rheumato

To review the pharmacologic, pharmacokinetic, efficacy, and safety data of golimumab, an anti-tumor necrosis factor alpha (TNF-α) monoclonal antibody

Expires on: Jan 01, 2013

City: , AL

Cost: $ 10.00

Contact Hours: 0.1

Link to Program: http://www.pharmace.com/abstracts/2010/golimumab.html

Specialty / Area of Interest: Rheumatology

Category: Pharmacy

Presenter / Author: The Annnals of Pharmacotherapy

Provider of Program: PharmaCE